Authors: Refolo, LM Pappolla, MA LaFrancois, J Malester, B Schmidt, SD Thomas-Bryant, T Tint, GS Wang, R Mercken, M Petanceska, SS Duff, KE

Citation: Lm. Refolo et al., A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenicmouse model of Alzheimer's disease, NEUROBIOL D, 8(5), 2001, pp. 890-899

Authors: Nixon, RA Mathews, PM Cataldo, AM Mohan, PS Schmidt, SD Duff, K Berg, M Marks, N Peterhoff, C Sershen, H

Citation: Ra. Nixon et al., In vivo perturbation of lysosomal function promotes neuro-degeneration in the PS1(M146V)/APP(K670N,M671L) mouse model of Alzheimer's disease pathology, ALZHEIMER'S DISEASE, 2001, pp. 687-695

Authors: Janus, C Pearson, J McLaurin, J Mathews, PM Jiang, Y Schmidt, SD Chishti, MA Horne, P Heslin, D French, J Mount, HTJ Nixon, RA Mercken, M Bergeron, C Fraser, PE St George-Hyslop, P Westaway, D

Citation: C. Janus et al., A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease, NATURE, 408(6815), 2000, pp. 979-982

Authors: Kovacs, DM Mancini, R Henderson, J Na, SJ Schmidt, SD Kim, TW Tanzi, RE

Citation: Dm. Kovacs et al., Staurosporine-induced activation of caspase-3 is potentiated by presenilin1 familial Alzheimer's disease mutations in human neuroglioma cells, J NEUROCHEM, 73(6), 1999, pp. 2278-2285